Skip to content

Treatment of abnormal cholesterol levels in the blood with Unani medicine

Evaluation of the safety and efficacy of Qurs Tinkar for the management of dyslipidemia - A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055320
Enrollment
45
Registered
2023-07-18
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Qurs Tinkar: 2 tablets of 500mg each twice daily with water after meals for 3 months. Control Intervention1: Atorvastatin: 20mg once a day after meals at night for 3 months

Sponsors

Luqman Unani Medical college hospital and research centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Participants of any gender. -Age between 20 and 60 years. -Participants with serum cholesterol more than or equal to 200mg per dL, serum triglycerides(TG) more than or equal to 150mg per dL, Low Density Lipoprotein cholesterol (LDL) more than or equal to 130mg per dL, High Density Lipoprotein (HDL) less than or equal to 40 mg per dL.

Exclusion criteria

Exclusion criteria: -Participants with comorbidities such as IHD, hypertension, diabetes, chronic kidney disease, malignancy, and other aggravating conditions. -Pregnant & lactating women

Design outcomes

Primary

MeasureTime frame
Changes in the levels of: LDL-C HDL-CTimepoint: At baseline and 3 months.

Secondary

MeasureTime frame
Changes in the levels of: Total cholesterol, Triglycerides, Non-HDL-C, Very Low Density Lipoprotein VLDL, Total Cholesterol HDL Cholesterol Ratio, FBS, SGOT, SGPT, ALP, Serum Creatinine, & Blood Urea NitrogenTimepoint: At baseline & 3 months.

Countries

India

Contacts

Public ContactD Nazim Husain

Luqman Unani Medical College Hospital and Research Center

drmqkhan@yahoo.com9849438319

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026